Merrill Lynch analyst Bob Hopkins reiterated a Buy rating on Intuitive Surgical (NASDAQ: ISRG) today and set a price target of $600. The company’s shares closed yesterday at $522.29.
According to TipRanks.com, Hopkins is a 4-star analyst with an average return of 9.7% and a 66.7% success rate. Hopkins covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Edwards Lifesciences, and Integra Lifesciences.
Currently, the analyst consensus on Intuitive Surgical is a Moderate Buy with an average price target of $575.50, a 10.2% upside from current levels. In a report issued on October 9, Piper Jaffray also upgraded the stock to Buy with a $600 price target.
.
See today’s analyst top recommended stocks >>
Based on Intuitive Surgical’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $255 million. In comparison, last year the company had a net profit of $298 million.
Based on the recent corporate insider activity of 98 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
